Focalyx Technologies is a small but growing medical software device company. Our MRI-TRUS fusion system for precision targeting of prostate cancer was developed by one of the world’s leading medical image fusion research teams. It’s now a fully CE-marked and FDA cleared medical device used to improve patient care in Europe and the USA.